Clinical Trial Update: Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People [NA]

View source ↗

Summary

Clinical trial evaluating Aframomum seed extract for anxiolytic effects in elderly individuals; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Aframomum seed extract (Aframomum seed extract)

Snippet

Sponsor: Nektium Pharma SL | Conditions: Situational Anxiety | NA | Status: COMPLETED